International Journal of Radiation Oncology Biology Physics

Article	Citations
The R's of Radiation Therapy: Do We Need More or Do We Move On?	184
If Medicine were my Spouse	128
In Regard to Langé et al	111
Mind Over Matter: Complete Craniospinal Irradiation or Just Treat the Spine	104
Association of Inpatient Radiation Oncology Consult Timing with Length of Hospitalization and Opioid Utilization	98
Effect of Postmastectomy Radiotherapy in Breast Cancer Patients according to Pathologic Nodal Status and Molecular Subtype after Neoadjuvant Chemotherapy	90
Optimal Threshold of Smoking in Pack-Years and its Association with Survival Outcomes Among Patients Treated with Chemoradiation for Head and Neck Cancer	89
Brachytherapy Capacity for Management of Cervical Cancer in Low- and Middle-Income Countries: An Updated IAEA Database Analysis	84
Radiation Necrosis Risk in NSCLC Patients Receiving EGFR TKIs or ALK Inhibitors	77
The LMP1/Lgals1-NF-Kb-IRF1-PDL1 Axis Promotes Immune Escape in Nasopharyngeal Carcinoma	76
Dose-Escalated Ablative Radiotherapy as Definitive Treatment for Unresectable and Recurrent Intrahepatic Cholangiocarcinoma	74
Salvage Ablative Radiation Therapy for Isolated Intraabdominal Recurrences of Hepatocellular Carcinoma	74
Breast Cancer Radiotherapy Experience in a Newly Established Cancer Center in Nigeria	74
Trends in Private Equity Involvement in Oncology Practices in the United States	69
Risk of Diabetes Mellitus after Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	67
Hypofractionated vs. Conventionally Fractionated Radiotherapy for Glioblastoma: Peripheral Blood Leukocyte Comparison prior to and Following Chemoradiation	66
In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Abdominal Oligometastases	65
Clinically Consistent Prostate Cancer Outcome Prediction Models with Machine Learning	63
Perineural Invasion Combined with Pattern C of the Silva Classification System Correlates Poor Prognosis in Cervical Adenocarcinoma Following a Radical Hysterectomy	62
Prevalence and Functional Impact of Vertigo among Long Term Survivors of Head and Neck Cancer	60
Does hippocampal atrophy correlate with patient-reported adaptive function one year following radiotherapy? Results from a prospective trial	57
Assessment of Nutritional and Imaging Biomarkers to Predict PEG Tube Placement in Non-HPV-Associated Head and Neck Patients Undergoing Concurrent Chemoradiotherapy	56
A National Cancer Disparities Analysis of Pacific Islanders Who Decline Radiation Therapy and Impacts on Overall Survival	56
Novel Enhancement of Checkpoint Inhibition Using Pulsing Radiotherapy with Concurrent and Adjuvant CPI for LAHNSCC in Elderly Patients Considered Ineligible for Curative Intent Therapy	56
Lymph Node Metastasis Spread Patterns and the Effectiveness of Prophylactic Neck Irradiation in Sinonasal Squamous Cell Carcinoma (SNSCC)	54

Predictors of Interstitial Brachytherapy Utilization in Locally Advanced Cervical Cancer and Impact on Overall Survival	53
Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Patients	52
Novel Bioprinted Pancreatic Tumor Model: A Translational Tool for Radiotherapy, Chemotherapy and Immunotherapy Efficacy Studies	52
Clinical Outcomes in High Risk WHO Grade II Glioma Patients Treated with Upfront TMZ-Based Chemoradiotherapy	49
Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer	49
Issue Highlights page	48
Postoperative Radiotherapy can Improve the Disease-Free Survival of EGFR Wild Type Patients with pN2 NSCLC after Complete Resection and Adjuvant Chemotherapy	48
Effectiveness of Adjuvant Radiotherapy for High Recurrence Risk Patients with Upper Tract Urothelial Carcinoma	47
The Maximum Standardized Uptake Value in Patients with Recurrent or Persistent Prostate Cancer after Radical Prostatectomy and PSMA-PET-Guided Salvage Radiotherapy – A Multicenter Retrospective Analys	47
Withdrawn	47
NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable St	46
Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT): A Single Institution, Dose De-Escalation, Phase II Trial	46
Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results	46
The Use of Breast Cup Immobilization in Radiation Therapy and Patient Reported Outcomes on Cosmesis and Pain	46
Withdrawn	45
Outcomes Associated with the Use of Tissue Equivalent Bolus Tailored by Skin Involvement Status in Postmastectomy Radiotherapy: A Single-Blinded Randomized Clinical Trial	45
Improving Interpretability of Machine Learning in Head and Neck Radiation Therapy Pretreatment Physics Plan Reviews	45
Comparison of Diagnostic PET and 4D CT-Based Tumor Delineation for Oligometastatic Lung Tumors	45
Disease-Free Survival of Patients with Muscle Invasive Bladder Cancer Treated by Radical Cystectomy vs. Bladder-Sparing Therapy at a Nationwide Level	44
The Utility of Mean Apparent Diffusion Coefficient Value in Patients with Prostate Cancer Treated with Definitive Radiotherapy	44
Effects of Expansion Size from Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Conventionally Fractionated Radiotherapy for WHO Grade I Meningiomas	43
Evaluation of Patient and Tumor Features to Optimize Urothelial Metastasis Treatment	43
Intraoral Gavage of Second-Generation Probiotic Lactobacillus Reuteri Releasing IFN-β (LR-IFN-β) Mitigates Intestinal Irradiation Toxicity and Improves Survival During Whole Abdomen Irradiation (WAI)	43
Association between Liver Metastases and Treatment Response in Patients with Metastatic, Microsatellite Stable Colorectal Cancer Treated with Radiation Therapy and Dual Immune Checkpoint Blockade	42
Communicating the External Beam Radiotherapy Experience (CEBRE) Discussion Guides: Real World Implementation and Evaluation	42
Is a Deep Learning Based Segmentation Model Trained on planning CTs Transferable for Segmentation of Organs at Risk in Replanning CTs?	41
Stereotactic Body Radiation Therapy for Large Volume Solid Tumor Spinal Metastases Involving Three or More Contiguous Vertebral Levels	41
In Reply to Takiar and Beadle	41
Pre-Clinical Validation of Targeting Cholesterol Metabolism for Radiotherapy Sensitization in Head and Neck Cancer	40
Single Dose vs. Fractionated High-Dose Rate Brachytherapy in Localized Prostate Cancer: Long Term Results	40
Withdrawn	40
Phase II Clinical Trial of Hypofractionated Image-Guided Proton Therapy with 12 Fractions for Prostate Cancer	40
The Baseline Serum Lipid Levels and Outcomes of NSCLC Patients Receiving Immunotherapy Combined or Non-Combined with Radiotherapy: A Single Center Retrospective Study	40
A Randomized Controlled Phase Ⅱ Study of Nab-Paclitaxel vs. Paclitaxel plus Cisplatin in Concomitant Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer	40
Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled Analysis	40
Withdrawn	39
Identification and Dosimetric Analysis of Axillary Substructures Associated with Breast Cancer Related Lymphedema	39
Rays Over Knife	39
Comparison of Two Phase II Trials of Neoadjuvant Temozolomide Followed with Concomitant and Adjuvant Temozolomide and Hypofractionated Accelerated Radiotherapy with or without Metformin in Patients wi	38
Evaluating Heterogeneity of Hippocampal Avoidant Whole Brain Radiotherapy (HA-WBRT) Treatment Effect on Neurocognitive Function (NCF): Secondary Analysis of NRG-CC001	36
Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule	36
Real Time Volumetric MRI for MR-Guided 3D Motion Tracking via Sparse Prior-Augmented Neural Representation Learning	36
Maximization of Peak-to-Valley Dose Ratio and Normal-Tissue Survival Fraction for Proton Minibeam Radiation Therapy	36
The Dutch Initiative for the Model-Based Selection of Patients for Proton Therapy – A Federated Learning IT Infrastructure	35
Incidence of Major Depression, Suicidal Ideation, and Mental Health Treatment Amongst Cancer Survivors	35
Prognostic Significance of the Novel Nutrition-Inflammation Marker of Lymphocyte-C-Reactive Protein Ratio in Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy	35
Largest Real-World Data of Regional Nodal Irradiation Using Ultra-Hypofractionated 5-Fraction Adjuvant Radiation Therapy for Breast Cancer from a Single Institute in India	34
Deployment of a Deep Learning Automated Cardiac Sub-Structure Contouring Algorithm to Measure Coronary Dose Exposure Trends in Lung Cancer Radiation Therapy	34
Financial Toxicity in Patients with Gynecologic Cancer Undergoing Brachytherapy	34
IL-1β+ Tumor Associated Macrophages Induced by Type I Interferon Initiates Radiotherapy-Mediated Abscopal Effect	33

Initial Experience with the Commercial Electron FLASH Research Extension	33
Prospective Longitudinal Assessment of Quality of Life after Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-Based SABR-5 Phase II Trial	33
Validation of Lexicographic Optimization-Based Planning for Brain Metastases Radiosurgery with Coplanar Arcs	33
Correlation between Lymph Node Regression Grading and Tumor Regression Grading after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	32
In Regard to Hammer et al.	32
Randomized Clinical Trial of Tele-Surveillance and Remote Symptom Monitoring Compared to Standard Surveillance for HPV-Associated Oropharynx Cancer with No Evidence of Disease on Post-Treatment Imagin	32
Issue Highlights page	32
Interpretable Deep Learning Identified the Significance of 1 Gy Volume on Lymphopenia after Radiotherapy in Breast Cancer	32
DCE-MRI-Based Atlas for Prostate Bed Recurrence after Radical Prostatectomy: Consistency of CTV Delineation with the Available Contouring Guidelines	32
Less Is More: A Hypofractionated Approach	32
Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study	32
How the Underlying Etiology of Cirrhosis Impacts Response to SBRT	32
A New Pos-SIB-ility for Prostate and Pelvic Nodal Radiation Therapy in High-Risk Localized Prostate Cancer	32
Incidence of Flap Failure Following Sinonasal Surgery, Flap Reconstruction and Postoperative Proton Radiation Therapy	31
Balancing Quality and Efficiency of Head and Neck Contour Revision for Online Adaptive Radiotherapy	31
The Effect of Package Time on Locally Advanced Oral Cavity Cancer Outcomes	31
HyperArc Planning for Benign Intracranial Pathologies: A Prospective Analysis on Plan Quality, Delivery, Control and Toxicity	31
Vertex Position Optimization for LATTICE Therapy	31
Hyperfractionated and Accelerated Reirradiation for Angiosarcoma Following Breast-Conserving Therapy: Long-Term Clinical Outcomes	31
Arytenoid-Sparing Intensity-Modulated Radiotherapy for Early-Stage Glottic Cancer	31
Symptomatic Posttreatment Edema after Stereotactic Radiotherapy for Intracranial Meningiomas: Patterns and Predictive Factors	31
Sarcopenia as a Predictor of Neoadjuvant Therapy-Related Toxicity in Esophageal Squamous Cell Carcinoma Patients	31
Dose-volume Predictors of Radiation Pneumonitis Following Thoracic Hypofractionated Radiotherapy	30
The Impact of TP53 Mutations and Use of the TP53-Mutation-Reactivating Agent APR-246 on Metastatic Castrate-Sensitive Prostate Cancer	30
Prospective, Cell-Free Circulating Tumor DNA (ctDNA) Profiling in Locally Advanced Lung Cancer Treated with Chemoradiation	30
A Molecular Approach to Characterize the Effects of Fluence, Fluence Rate and LET on Radiation Damage	30
In Reply to Goyal and Madan	30
Putting the Brakes on Xerostomia in Oropharyngeal Cancer: Can Brachytherapy Be the Key?	30
International Clinical Radiotherapy Audit in CCCN- iPAAC Project	30
Assessment of Cardiac Radiation Dose in the Co-60 Prone Based Stereotactic Partial Breast Irradiation (CP-sPBI) Using the Distance from the Heart to the Planning Treatment Volume as a Surrogate Marker	30
Contralateral Nodal Relapse (CLNR) in Well Lateralized Oral Cavity Cancer Treated Ipsilaterally with Surgery and Adjuvant Radiotherapy with or without Concurrent Chemotherapy: A Retrospective Audit	30
Dosimetric Factors Associated with Esophagitis Following Hypofractionated Radiotherapy to the Thorax	29
Multitask AI Models for the Joint Prediction of Overall Survival, Progression-Free Survival, and Death without Progression as a Composite Endpoint for LA-NSCLC Patients Treated with Chemoradiotherapy	29
Rapid Reinstatement of Cancer Care after Hurricane Ian	29
A Radiation Therapy Contouring Atlas for Delineation of the Level I-II Axilla in the Prone Position	28
A Novel Multi-Channel Tandem Applicator for Direction Modulated Brachytherapy	28
Evaluating the Use of SGRT and Abdominal Compression Device for Improved Patient Positioning in Liver Cancer Radiotherapy	28
Combined Brachytherapy and Ultra-Hypofractionated Radiotherapy for Intermediate-Risk Prostate Cancer: Comparison of Toxicity Outcomes Using a High-Dose Rate (HDR) vs. Low-Dose Rate (LDR) Brachytherapy	28
Accelerated Partial Breast Irradiation (APBI) Using Five Daily Fractions: A Prospective, Phase II, Multi-Center Trial of Cosmetic Outcomes and Toxicity: Final Results	28
Clinical Outcomes in cN+M0 Bladder Cancer Patients: Can Bladder be Spared?	28
Prospective Evaluation of Locoregional Control in Oral Cavity Squamous Cell Carcinoma with Infratemporal Fossa Involvement Treated with Surgery and Adjuvant Concurrent Chemoradiotherapy	28
Irradiation Dose to the Swallowing Muscles Impacts Nutritional Status in Head and Neck Cancer Patients: The Prospective Randomized HEADNUT Trial	28
Long Term Results of Prostate Cancer Patients Treated with Cs131 LDR Brachytherapy Compared with Recently Published SBRT Data	28
Geometric and Dosimetric Evaluation of Using a Novel Tongue Positioning Device to Reduce Tongue Motions during Radiation Therapy for Head and Neck Cancer	27
Atypical Nodal Involvement From an Atypical Meningioma	27
Interprofessional Teaming: Is a One-hour Novel Didactic/Interactive Leadership Class Feasible?	27
Early Normal Tissue Effects and Bone Marrow Relative Biological Effectiveness for an Actinium 225-Labeled HER2/neu-Targeting Antibody	27
Advancing beyond the Hippocampus to Preserve Cognition for Patients with Brain Metastases: Dosimetric Results from a Phase 2 Trial of Memory-Avoidance Whole Brain Radiotherapy	27
Improving the Efficacy and Safety of Concurrent Chemoradiotherapy by Neoadjuvant Chemotherapy: A Randomized Controlled Study of Locally Advanced Cervical Cancer with a Large Tumor	27
Evidence for Persistent Radiation-Related Injury to the Immune System in Patients With Local Breast Cancer	27
Issue Highlights page	27
Toxicity Outcomes at 18 Months for Cs-131 Low-Dose-Rate Prostate Brachytherapy Compared to I-125 and Pd-103	27
Withdrawn	27
Artificial Intelligence Auto Contouring and its Impact on Resident Education	27
Performance of Multiparametric MRI and PET Imaging in Identifying and Localizing Locally Radiorecurrent Prostate Cancer in a Phase I/II Trial of Focal Salvage HDR	27
Small Molecule Inhibitors Targeting Transgelin-2-Actin Interaction for Therapeutic Intervention in Glioblastoma	26
Prospective and Comprehensive Characterization of an Inpatient Radiation Oncology Consult Service: Examining Interdisciplinary Coordination of Palliative Radiation Access and Receipt	26
Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial	26
Quantifying the Effect of 4-Dimensional Computed Tomography–Based Deformable Dose Accumulation on Representing Radiation Damage for Patients with Locally Advanced Non-Small Cell Lung Cancer Treated wi	26
Expression of concern to “The Critical Role of Dysregulated RhoB Signaling Pathway in Radioresistance of Colorectal Cancer” Liu et al, Int J Radiat Oncol Biol Phys, 2019;104(5):1153-1164.	26
Beyond Randomized Controlled Trials: Embracing Pragmatism for Evidence-Based Online Adaptive Radiation Therapy	26
Dosimetric Comparison between Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy in Both Semi-Lateral Decubitus and Supine Positions for Left Breast Cancer Radiation T	26
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors	26
Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck Cancer	26
Molecular Changes in Breast Cancer Induced by Radiation Therapy	26
Dose Painting Radiotherapy Guided by Diffusion-Weighted Magnetic Resonance vs. 18F-FDG-PET/CT in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized, Controlled Clinical Trial	26
Surgical Status in the Era of New Molecular Diagnostics: Insights from a Single-Center Case Series Report in China	26
The Combination of Radiation Therapy and Immunotherapy Is Effective and Well-Tolerated for Unresectable Biliary Tract Cancer	25
Histologic Classifier of Radiosensitivity to Spine Stereotactic Body Radiation Therapy	25
eVOLVE-HNSCC: A Global Phase 3 Study of Consolidation Volrustomig Therapy After Definitive Concurrent Chemoradiotherapy (cCRT) in Patients (PTS) with Unresected Locally Advanced Head and Neck Squamous	25
Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure	25
Radiation Therapy for Meningiomas – Where Do We Stand and What's on the Horizon?	25
Cord Blood–Derived Endothelial Progenitor Cells Promote In Vivo Regeneration of Human Hematopoietic Bone Marrow	25
Retrospective Analysis of Proton Beam Therapy for Postoperative Locally Recurrent Rectal Cancer	25
Clonal Hematopoiesis of Indeterminate Potential After Radiation Therapy	25
AHEAD-MERIT: A Phase II/III Trial of First Line (1L) BNT113 Plus Pembrolizumab in Unresectable Recurrent or Metastatic HPV16+ HNSCC	24
Pre-Surgery Allostatic Load in Head and Neck Cancer	24
Proton Craniospinal Irradiation for Patients with Solid Tumor Leptomeningeal Metastasis- Final Analysis of a Phase II Study	24
Pilot Study Evaluating the Addition of Cemiplimab in BRAF Mutant Anaplastic Thyroid Cancer After Progression on Dabrafenib and Trametinib	24
Evaluating ctHPVDNA Clearance Kinetics During Chemoradiation Across HPV-Associated Cancer Types Using an Ultrasensitive WGS Platform	24

Withdrawn	24
In Silico Optimization of Novel PSMA-Targeted Ligands for Actinium-225 Radiotheranostic Therapy	24
Association Between Lymphocyte Kinetics and Outcomes in Patients with Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma (LR-HNSCC) Treated with Hyperfractionated Re-Irradiation and Immuno	24
Management of Oligoprogression in the Thorax—Are We Making This Too Complicated?	24
Oligometastatic Head and Neck Squamous Cell Carcinoma: Is SABR the Solution?	23
The Feasibility Study of Dual-Energy CT Virtual Non-Contrast instead of True Non-Contrast in Proton Radiotherapy Dose Calculation	23
Assessment of the Effective Dose to Immune Cells as an Independent Predictor of Durvalumab Response in Patients With Non-Small Cell Lung Cancer After Chemoradiotherapy: A Multicenter Study	23
External Beam Radiation therapy After Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for Treatment of Inoperable Hepatocellular Carcinoma: A Randomized Phase 3 Trial	23
Doing Our Best With What We Have (and Know)	23
The Onus of Proof: Evidence-Based Adoption of Advanced Radiation Therapy Technologies	23
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer	23
Prognostic Factors of Mandibular Osteoradionecrosis Including Accurate Colocalization of Avulsions and Dosimetric Dental Mapping Software, a Case-control Study	23
Stereotactic Body Radiotherapy Combined With Lenvatinib With or Without PD-1 Inhibitors as Initial Treatment for Unresectable Hepatocellular Carcinoma	23
A Novel Dose Rate Optimization Method to Maximize Ultrahigh-Dose-Rate Coverage of Critical Organs at Risk Without Compromising Dosimetry Metrics in Proton Pencil Beam Scanning FLASH Radiation Therapy	23
In Reply to Onal et al	23
Stereotactic Ablative Radiotherapy for the Treatment of Pancreatic Metastases from Renal Cell Carcinoma	23
Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy	23
About the cover image	23
The Role and Mechanism of Ferroptosis Mediated by METTL3-m6A Modification in Regulating Radioresistance of Esophageal Cancer	23
Genomic and Transcriptomic Remodeling by Neoadjuvant Chemoradiotherapy (nCRT) and the Indicative Role of Acquired INDEL Percentage for nCRT Efficacy in Esophageal Squamous Cell Carcinoma	22
TEAching Mentoring in Radiation Oncology (TEAMRO): a ROECSG GME multi-institutional pilot study on teaching mentorship skills to residents	22
Deep Learning Based Prognostic Prediction in Oropharyngeal Cancer Patients Using Multiparametric MRI Inputs	22
Low Utilization of External Beam Radiation Therapy for Patients With Unresectable Hepatocellular Carcinoma: An Analysis of the United Network for Organ Sharing Database	22
Identification of Triapine as a Novel Radiosensitizer in Glioblastoma	22
Repeated Carbon-Ion Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma	22
KDM3B Single-Nucleotide Polymorphisms Impact Radiation Therapy Toxicity Through Circular RNA-Mediated KDM3B Expression and Inflammatory Responses	22
Calculation of the Absolute Risk of a Radiation-Induced Acute Coronary Event in Patients With Breast Cancer: A Hypothesis Incorporating Indian Ethnicity	22
Distance Traveled by Patients Globally to Access Radiotherapy: A Systematic Review	22
A First Look at Equity, Diversity, and Inclusion of Canadian Medical Physicists: Results From the 2021 COMP EDI Climate Survey	22
Different Detection Rates of Brain Metastasis in Different Pathological Types of Lung Cancer by 18F-FAPI PET/CT	22
Local Therapy for Oligometastatic Disease—Cart Before the Horse?	22
In Reply to Akhtar et al	22
Conventional Fractionated Elective Nodal Irradiation Preserves Early Antitumor Immunity and Efficacy Compared With Hypofractionated Protocols	22
Can Surface-Guided Radiation Therapy (SGRT) be Used to Monitor Intrafraction Motion of Patients Receiving Accelerated Partial Breast Irradiation (APBI)?	22
The Association of Genetic Polymorphisms in the TNF-α Gene and Mucositis in Head and Neck Cancer Patients Treated with Combined Radiotherapy and Chemotherapy	22
A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy	22
A Phase 2 Multi-Center, Placebo-Controlled, Randomized Study to Assess the Safety and Efficacy of Parenteral TK-90 for Preventing Radiation-Induced Mucositis in Patients with Squamous Cell Carcinoma o	21
Development of a Consensus Checklist for Systematic Radiation Treatment Plan Review	21
Feasibility of an Online MR-Guided Scan-Plan-Treat Workflow for Emergency Palliation	21
Pivotal Roles of Tumor-Draining Lymph Nodes in the Abscopal Effect from Combined Immunotherapy and Radiotherapy	21
Re-Irradiation in Children with Recurrent Medulloblastoma	21
Mid-Range Arc Therapy—Enhancing Dosimetric Quality, Robustness and Efficiency for Proton Treatment with Simple Planning	21
Withdrawn	21
Toxicity Evaluation of Dose-Escalation in Hypofractionated Regional Nodal Irradiation for Breast Cancer: A Retrospective Study	21
Stereotactic Body Radiation Therapy Augmented Checkpoint Inhibitor Immunotherapy Response in Heavily Pretreated Metastatic Osteosarcoma	21
In Reply to Hannoun-Levi et al	21
Clinical Outcomes of Patients with Early-Stage Breast Cancer Treated with Five-Fraction Partial Breast Irradiation vs. Intraoperative Radiation Therapy	21
Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis	21
Micro-Costing Analysis of Rectal Spacers in Prostate Cancer Treatment with Radiotherapy	21
Partial Kidney Radiation Modeling for the Effect of Kidney Dysfunction in Pediatric Cancer	21
Impact on Pulmonary Function in a Randomized Trial of Single-Fraction and Multifraction Stereotactic Body Radiation Therapy for Pulmonary Oligometastatic Disease: An Analysis of TROG 13.01 (SAFRON II)	21
Using Holistic Residency Applicant Review and Selection in Radiation Oncology to Enhance Diversity and Inclusion—An ASTRO SCAROP-ADROP-ARRO Collaboration	21
Antibiotic-Induced Gut Microbiota Depletion Accelerates the Recovery of Radiation-Induced Oral Mucositis in Rats	21
Conventionally Fractionated Reirradiation of Recurrent High-Grade Gliomas: A Look at Dose Escalation and Safety	21
Risk of Death in Octogenarians with Intermediate Risk Prostate Cancer Who Are Treated with Radiation Therapy (RT) Plus Androgen Deprivation Therapy (ADT) Versus Radiation Alone, an NCDB Analysis	21
Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Radiation Therapy in Two Fractions for Locally Recurrent Prostate Cancer after Definitive Radiation Therapy	21
Personalized Minimal Residual Disease Profiling Predicts Prognosis in Esophageal Carcinoma Undergoing Definitive Radiotherapy	21
Long-Term Outcomes after Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer	20
Initial Clinical Experience of Cherenkov Imaging in Sub-Total Total Skin Electron Therapy Identifies Opportunities to Improve Daily Set-Up QA	20
Local Disease Control in Patients with Erdheim-Chester Disease Treated with External Beam Radiation Therapy	20
A Simple Method to Generate Descriptive Images for Recurrent Cervix Cancer Using Predictive ResNet Model Weights and Feature Maps	20
Lost in Lunglation: Unraveling the Mystery of Idiopathic Pulmonary Syndrome Post-Total Body Irradiation for Bone Marrow Transplant	20
Comparison between Proton LET-Dependent RBE Dose and Photon Physical Dose for Acute Radiation Dermatitis in Caucasian and African-American Breast Cancer Patients Undergoing Radiation Therapy	20
Timing of Once-Daily Thoracic Radiotherapy and Clinical Outcomes in Patients with Limited-Stage Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy	20
A Pilot Comparative Study of Mouthbite Devices and Their Effect on Patient Experience and Treatment Setup	20
Adaptive Radiation Fractionation in Head and Neck Cancer through Modeling Tumor Volume Dynamics	20
Non-Canonical p16-SP1 Signaling in Head and Neck Cancer Potentially Affects Cell Plasticity	20
Managing for Daily Improvement: A System for Real-Time Quality Improvement and Patient Safety	20
A Meta-Analysis of Daily vs. Nonconsecutive Fractionation Schedules for Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer	20
1.5T MR-Guided Daily Adaptive Radiotherapy: Preliminary Clinical Report of the First 5000 Fractions	20
Reducing Patient Safety Risk with the Implementation of Intradepartmental Survey Program across a Multi-Site Large Teaching Institution	20
Applying GD-EOB-DTPA Enhanced MR to Unveil the Radiobiological Effect of Proton and Photon Therapy Based on the Longitudinal Evolution of the Focal Liver Reaction	20
Impact of Deep Learning Auto Segmentation Accuracy on Duodenal Dose-Volume Parameters for Pancreas SBRT Patients Treated with MR-Guided Online Adaptive Radiotherapy	20
Transforming into a Trauma-Informed Care Radiation Oncology Department: Training Program Design, Execution and Evaluation of our Program's Impact	20
A Microbial-Inspired Antibody-Drug Conjugate Unleashes Macrophage Functionalities for Cancer Immunotherapy	20
Association of Biologically Effective Dose and Survival in Patients Receiving Head and Neck Stereotactic Body Radiation Therapy	20
Predictive Analysis of DQA (Delivery Quality Assurance) Failures in Tomotherapy Plans: Utilizing Plan Parameters and Dosiomics	20
Evaluating the Efficacy of Novel MET-Targeting Camelid Derived Antibody as an Imaging Agent in Head and Neck Cancers	19
Local Control of Merkel Cell Carcinoma Treated with Standard of Care Radiation Therapy Compared to Palliative Dose Radiation Therapy	19
Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer is Underutilized but Increasing in the National Cancer Database 2010-2021	19
Estimating Risk of Biochemical Recurrence after RT Utilizing a Convolutional Neural Network	19
Multi-Omics Sequencing Unveils Tumor Microenvironment Remodeling Induced by Combined Radiotherapy and Immunotherapy in Microsatellite-Stable Locally Advanced Rectal Cancer	19
Treatment of Patients with Gastric Extranodal Marginal Zone Lymphomas (MZL) Using CBCT-based Adaptive Radiotherapy (ART) to Reduce Margins	19
“Big Jolts Like an Electric Shock:” Patient Perspectives on the Expectations, Experiences and Quality-of-Life Impact of Androgen Deprivation Therapy (ADT) for Prostate Cancer	19
Prognostic Factors for Early Demise Following Palliative Spatially Fractionated Radiotherapy	19
Multi-Modality Machine Learning Prediction Model of Hematologic Toxicity in Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	19
Impact of Resident-Lead Didactics on Referring Trainee Radiotherapy Knowledge and Consultation Comfort	19
The Positioning Accuracy of Individualized Open-Face Mask in Patients with Intracranial Tumors Receiving Radiotherapy - A Randomized Controlled Study	19
Development of Volumetric Quantitative Evaluation Software for Assessing Respiratory-Induced Target Motion	19
Climate-Smart Oncology: Can Hypofractionation Lighten Radiotherapy's Environmental Load?	19
A Phase II Trial of 5-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes	19
Time-Delayed Contrast-Enhanced T2-FLAIR and Accuracy of GTV Determination in Brain Metastases	18
Locoregional Recurrence and Survival Outcome of HER2-Low Breast Cancer Patients after Upfront Surgery and Adjuvant Radiotherapy	18
Time-Synchronized Immune-Guided Partial Tumor Irradiation: Proof-of-Principle Trial (NCT04168320)	18
Role of Retreatment with Stereotactic Ablative Body Radiotherapy (SABR) in Oligorecurrent Mesothelioma: A Retrospective Monocentric Study	18